Pulmonary Arterial Hypertension Treatment Market

Pulmonary Arterial
Hypertension
Treatment Market
Share, Global Trends,
Analysis, Research, Report,
Opportunities,
Segmentation and Forecast,
2016
Future Market Insights
www.futuremarketinsights.com
sales@futuremarketinsights.com

Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting
services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes,
technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends.
We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC.
Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and
Retail.
We have a global presence with delivery centers across India specializing in providing global research reports and country
research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India.
We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for
our client.
Research Capabilities
• Customized Research
• Syndicated Research
• Investment Research
• Social Media Research
Sector Coverage
• Automotive and Transportation
• Electronics, Semiconductor, and ICT
• Retail and Consumer Products
• Industrial Automation and Equipment
• Chemicals & Materials
• Food and Beverages
• Services and Utilities
• Energy, Mining, Oil, and Gas
Customized
Research
Syndicated
Research
Investment
Research
Social Media
Research
Subscription Information
For detailed subscription information please contact
Hari. T (Sr. Manager - Global Business Development)
T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268
Email: hari.t@futuremarketinsights.com

Report Description
According to World Health Organization (WHO), raised blood pressure is estimated to
cause 7.5 million deaths around the world. Hypertension is a risk factor for coronary
heart disease, ischemic and hemorrhagic stroke. In addition complications of
hypertension includes peripheral vascular disease, heart failure, renal impairment, retinal
hemorrhage and visual impairment.
Having family history of Pulmonary Arterial Hypertension, change in life style, unhealthy
food, and physical inactivity causes hypertension.
To treat pulmonary atrial hypertension following treatments are available
Medication
Surgeries
Medications include blood vessel dilators (vasodilators), Endothelin receptor antagonists,
phosphodiesterase III inhibitors, calcium channel blockers, anticoagulants, diuretics.
Browse Full Report@ http://www.futuremarketinsights.com/reports/pulmonary-arterialhypertension-treatment-market
Atrial septostomy and Transplantation are the two surgery option for patients who
suffering from severe pulmonary atrial hypertension. Transplantation is may be an option
for younger people who are suffering from idiopathic pulmonary hypertension.

Report Description
Pulmonary Arterial Hypertension Treatment Market: Drivers and Restraints
According to World Health Organization, Globally the prevalence rate of hypertension
was 40% in adults who aged 25 and above in the year 2008. The prevalence rate is high in
Africa region and Americas having less prevalence rate in hypertension. Change in the life
style, family history of pulmonary atrial hypertension, unhealthy food, and physical
inactivity are the risk factors for hypertension as well as drivers for this market. Raising
the geriatric population around the world also driver for pulmonary atrial hypertension
treatment market. Guidelines form government organizations such as World Health
Organization (WHO), Center for Disease Control and Prevention plays a major role in the
prevention of pulmonary atrial hypertension treatment.
Pulmonary Arterial Hypertension Treatment Market: Segmentation
Pulmonary Arterial Hypertension Treatment Market is segmented into following types:
Based on Treatment
Medication
Based on End User
Hospital
Drug store
Hospital Pharmacies

Report Description
Request Free Report Sample@
http://www.futuremarketinsights.com/reports/sample/rep-gb-1218
Pulmonary Arterial Hypertension Treatment Market: Overview
With good awareness about healthcare among people and guidance from international
organizations about the Pulmonary Arterial Hypertension Treatment, the market is
expected to have a healthy growth in the forecast period (2016-2026)
Pulmonary Arterial Hypertension Treatment Market: Region- wise Outlook
Depending on geographic regions, the global Pulmonary Arterial Hypertension Treatment
market is segmented into seven key regions: North America, South America, Eastern
Europe, Western Europe, Asia Pacific excluding Japan, Japan and Middle East & Africa.
Pulmonary Arterial Hypertension Treatment is high in North America because it is highly
developed region, having good healthcare setup and people are having good awareness
about health care. Asia Pacific is expected to grow at a remarkable CAGR. Europe also
having good growth in this market.
Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1218
Pulmonary Arterial Hypertension Treatment Market: Key Players
Some of the key players in this market are

Report Description
Pfizer inc.
Bristol myers co
Novartis AG.
GlaxoSmithKline Pharmaceuticals Limited
Baxter
Dr. Reddy’s Laboratories Ltd.

Thank You!
To know more about us, please visit our website:
www.futuremarketinsights.com
For sales queries or new topics email us on:
sales@futuremarketinsights.com
For other queries contact: Mr. Sudip Saha
Future Market Insights: 616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
T: +1-347-918-3531 | D: +1-845-579-5705